Open AccessA meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus
Author(s) -
Lei Han,
Hongwei Zhang,
Jun Xie,
Qi Zhang,
Hongyang Wang,
Guangwen Cao
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i38.4321
Subject(s) - hbeag , lamivudine , medicine , hbsag , hepatitis b virus , relative risk , hepatitis b , meta analysis , randomized controlled trial , transmission (telecommunications) , virology , pregnancy , immunology , gastroenterology , confidence interval , virus , biology , electrical engineering , engineering , genetics
To determine the therapeutic effect of lamivudine in late pregnancy for the interruption of mother-to-child transmission (MTCT) of hepatitis B virus (HBV).